Unlike organized lymphoid tissue, the tumor microenvironment (TME) often includes a high proportion of immunosuppressive macrophages. We model the TME by culturing peritoneal cavity (PerC) cells that naturally have a high macrophage to lymphocyte ratio. Prior studies revealed that, following TCR ligation, PerC T cell proliferation is suppressed due to IFNγ-triggered inducible nitric oxide synthase expression. In this study we assessed the ability of PerC B cells to respond to surrogate activating signals in the presence of high numbers of macrophages. Surface IgM (BCR) ligation led to cyclooxygenase-mediated, and TLR-4 ligation to IL10-mediated, suppression of PerC B cell proliferation. In contrast, PerC B cells had a robust response to CD40 ligation, which could overcome the suppression generated by the BCR or TLR-4 response. However, the CD40 response was suppressed by concurrent TCR ligation. These results reveal the challenges of promoting B and T cell responses in macrophage-rich conditions that model the TME.
Tumors may include a high proportion of immune modulatory cells and molecules that restrain the anti-cancer response. Activation of T cells to eliminate cancer cells within the immune-suppressive tumor microenvironment remains a challenge. We have shown that C57BL/6J peritoneal cell culture models features of macrophage-dense tumors as TCR ligation fails to activate T cells unless IFNγ is neutralized or iNOS is inhibited. We tested other forms of T cell activation and found phytohemagglutinin (PHA) distinctive in the ability to markedly expand CD8 T cells in this model. IFNγ or iNOS inhibition was not necessary for this response. PHA triggered less IFNγ production and inhibitory PD-L1 expression than TCR ligation. Macrophages and CD44hi T cells bound PHA. Spleen T cell responses to PHA were markedly enhanced by the addition of peritoneal cells revealing that macrophages enhance T cell expansion. That PHA increases CD8 T cell responses within macrophage-dense culture suggests this mitogen might enhance anti-tumor immunity.
Tumors are often comprised of microenvironments (TMEs) with a high proportion of cells and molecules that regulate immunity. Peritoneal cavity (PerC) cell culture reproduces key features of TMEs as lymphocyte proliferation is suppressed by PerC macrophages (Mϕs). We monitored the expression of T cell stimulatory (Class II MHC, B7) and inhibitory (PD-L1) molecules by PerC APCs before and after culture and report here that IFNγ-driven PD-L1 expression increased markedly on PerC Mϕs after TCR ligation, even more so than seen with direct APC activation by LPS. Considering the high APC composition of and pronounced PD-L1 expression by PerC cells, it was surprising that blocking PD-1/PD-L1 interaction by mAb neutralization or genetic ablation did not relieve suppression. This result parallels TME challenges observed in the clinic and validates the need for further study of this culture model to inform strategies to promote anti-tumor immunity.
In lymphopenic environments, secondary lymphoid organs regulate the size of B and T cell compartments by supporting homeostatic proliferation of mature lymphocytes. Although this process operates in multiple clinically relevant settings, including after bone marrow transplantation and chemotherapy as well as in aging individuals, little is known about its underlying molecular mechanisms and functional consequences. In mice, mature naïve B cells include mostly follicular B (FoB) cells in spleen and lymph nodes, as well as specialized marginal zone B (MZB) cells in the spleen with innate-like functions and a capacity for rapid plasma cell differentiation. To identify mechanisms controlling the size and composition of the peripheral B cell pool, we developed a mouse model in which highly purified CTV-labelled B6-CD45.1 FoB cells were adoptively transferred intravenously to lymphopenic B6-CD45.2 Rag2-/- mice, lacking mature B and T cells, or control B6-CD45.2 lymphoid-replete recipients. Within two days after transfer of CD19+ CD93neg CD21int CD23high B6-CD45.1 FoB cells (106, >99% purity), CD45.1+ donor-derived B cells had upregulated expression of surface IgM (sIgM) and CD21 in the spleen of Rag2-/- recipients, but not in wild type control recipients. At day 4 and day 8, the majority of transferred B cells remained sIgMhi and CD21hi in Rag2-/- recipients and gradually showed decreased CD23 and sIgD as well as increased CD1d expression, consistent with loss of their FoB phenotype and acquisition of a characteristic MZB cell phenotype (sIgMhisIgDlow CD21hi CD1dhi CD23low). These phenotypic changes were followed by a burst of proliferation (CTV dilution) between day 4 and day 8 after transfer. Immunofluorescence microscopy of host Rag2-/- spleen sections at day 2 post-transfer identified clusters of transferred B cells localized around CD169+ macrophages at the white pulp/red pulp interface close to the marginal sinus, with subsequent proliferation in this area. We next investigated if Notch signaling regulates this transdifferentiation process, by analogy to its role in normal MZB cell homeostasis. Treatment of Rag2-/- recipients with blocking antibodies against Delta-like-1 Notch ligands (anti-DLL1) or Notch2 receptors (anti-NRR2) completely inhibited lymphopenia-induced FoB to MZB cell conversion and proliferation. To identify the cellular source of DLL1 Notch ligands, we studied transferred B cells in Rag2-/-;Ccl19-Cre+;Dll1f/f recipients, lacking Dll1 expression in all Ccl19-Cre+ fibroblastic reticular cells and their progeny. In these mice as compared to Rag2-/- recipients, FoB to MZB transdifferentiation was almost completely abrogated and transferred cells no longer clustered with marginal sinus-associated macrophages. Thus, stromal DLL1 Notch ligands are critical to regulate the size and composition of the splenic peripheral B cell pool in lymphopenic mice through DLL1/Notch2 interactions. Furthermore, FoB cells are not locked in their FoB cell fate, as commonly assumed, but are instead endowed with plastic transdifferentiation potential in response to DLL1/Notch2-mediated signals that function as a sensor of B cell lymphopenia. We speculate that these adaptive physiological functions of the Notch signaling pathway play an important role in the homeostasis of mature B cells within their stromal microenvironment, and that they can be hijacked during malignant transfomation in Notch-dependent mature B cell lymphomas such as CLL and marginal zone lymphoma. Disclosures Siebel: Genentech: Current Employment. Maillard:Allogene: Consultancy; Regeneron: Consultancy; Genentech: Consultancy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.